Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05823584
What this trial is testing

Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence

Who this might be right for
Hepatocellular Carcinoma
TCM Biotech International Corp. 207
Very early researchUnknownNCT05131698
What this trial is testing

Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma

Who this might be right for
TislelizumabLenvatinibTACE+1 more
Cancer Hospital of Guangxi Medical University 31
Not applicableStudy completedNCT05352204
What this trial is testing

Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas

Who this might be right for
Carcinoma, Hepatocellular
Zhejiang University 900
Not applicableLooking for participantsNCT06805552
What this trial is testing

Sarcopenia and Systemic Therapy in HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 270
Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Testing effectiveness (Phase 2)Looking for participantsNCT06695026
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Rznomics, Inc. 45
Not applicableStudy completedNCT01910909
What this trial is testing

Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Localized Non-Resectable Adult Hepatocellular Carcinoma
Samsung Medical Center 56
Not applicableNot Yet RecruitingNCT07045558
What this trial is testing

HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
RenJi Hospital 28
Not applicableLooking for participantsNCT07811687
What this trial is testing

Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function

Who this might be right for
Liver CirrhosisHCC - Hepatocellular CarcinomaHypersplenism
Northern Jiangsu People's Hospital 30
Not applicableNot Yet RecruitingNCT06069947
What this trial is testing

SALT for Liver Cirrhosis With HCC

Who this might be right for
HCCLiver Cirrhosis
RenJi Hospital 40
Not applicableUnknownNCT06205732
What this trial is testing

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

Who this might be right for
Carcinoma, Hepatocellular
Qianfoshan Hospital 100
Not applicableStudy completedNCT05720195
What this trial is testing

ALBI and PALBI Scores and HCC Prognosis

Who this might be right for
Hepatocellular Carcinoma (HCC) Prognosis
Sohag University 645
Not applicableUnknownNCT06325267
What this trial is testing

Clinical Characteristics of Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1,000
Testing effectiveness (Phase 2)UnknownNCT03864211
What this trial is testing

Thermal Ablation Followed by Immunotherapy for HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Xiangya Hospital of Central South University 145
Large-scale testing (Phase 3)Ended earlyNCT01821963
What this trial is testing

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Who this might be right for
Infection
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT03575806
What this trial is testing

Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection

Who this might be right for
Hepatocellular CarcinomaMalignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Very early researchStudy completedNCT02013492
What this trial is testing

Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Male Breast CancerRecurrent MelanomaStage IV Breast Cancer+5 more
William Carson 1
Not applicableLooking for participantsNCT06487663
What this trial is testing

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

Who this might be right for
Hepatocellular Carcinoma Non-resectableCholangiocarcinoma Non-resectableLiver Metastases+1 more
Tianjin Medical University Cancer Institute and Hospital 40
Not applicableLooking for participantsNCT07623265
What this trial is testing

Improving the Use of Immunotherapy to Treat Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)
Universitaire Ziekenhuizen KU Leuven 300
Post-approval studies (Phase 4)Study completedNCT00646100
What this trial is testing

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 164
Next Page